The year of 2021 started with some good news on the COVID-19 vaccines. However, the investigation of additional treatments is not over. Take a look at this recent living systematic review and network meta-analysis on the effectiveness of different interventions for coronavirus – BMJ 2020;370:m2980
Integration of community pharmacy in primary health care
During 2020, Pharmacy Practice – the journal has published an international series on the Integration of community pharmacy in primary health care. Key experts were invited to promulgate and disseminate country-based information on primary health care and community pharmacy/pharmacist.
Learn more at: Pharmacy Practice
Series on community pharmacy policy and vision
This article discuss the primary healthcare policy and vision for community pharmacy and pharmacists in the USA. Take a look at this paper and others from this interesting series in Pharmacy Practice, the Journal
Community pharmacists on the frontline against COVID-19
Take a look at this article that highlights the roles and activities of community pharmacists that can contribute towards the pandemia. Res Social Adm Pharm, 2020.
How many manuscripts should I peer review per year?
To keep the scholarly peer reviewing publishing wheel spinning, researchers should be aware of their role both as authors and reviewers. How many paper do you think you should review per year? Take a look at this editorial in Pharmacy Practice, 2020
Pharmacy journals: is there a classification?
Did you know that Pharmacy journals can be objectively classified into six different classes that represent different research subareas? A lexicographic analysis was recent performed to identify these scientific areas. Learn more at Res Social Adm Pharm. 2019
Understanding the impact of simulated patient
Simulated patients is a method frequently used to assess various dimensions of pharmacy practice, including to gain in‐depth knowledge of customer perceptions of service delivery, to measure performance against standards of service, to motivate, develop and encourage staff as a part of a training. Read more about this topic on this systematic review Int J Pharm Pract. 2019
Transition from the BPharm to the PharmD degree: what to expect?
The transition to the clinically orientated PharmD degree is seen as a natural evolution of the profession. However, some countries have both clinically-oriented and pharmaceutical sciences-oriented PharmD programme. Take a look on this recent review focuses on studies and opinions around issues of transition from the BPharm to the PharmD degree in the U.S., Japan, South Korea, Pakistan and Thailand.
The evolution of pharmacy practice research
The role of pharmacists has been changing globally over the past 30 years, moving away from a technical dispensing role to a more holistic cognitive role. Is important to consider the current evidence on the effectiveness of pharmacists’ contribution to patient care and towards recommendations for future research. See these two editorials: Can Pharm J (Ott). 2019;152(2) and Int J Pharm Pract. 2019;27(3).
Quality over quantity: how to improve the rigor and reproducibility of research?
A heated debate surrounds the significance of reproducibility as an
indicator for research quality and reliability. Different approaches are being taken to address this problem, including greater transparency in the pre-publication of study protocols, analysis plan and analysis code and data sharing. However, further incentives are needed. See the comments of the Australian chief scientist Alan Finkel in Nature 566, 297 (2019)